ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH SATURATION IN THE C-RING
申请人:REATA PHARMACEUTICALS, INC.
公开号:US20140179928A1
公开(公告)日:2014-06-26
This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:
wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.
Compositions and Methods of Treatment of Corneal Endothelium Disorders
申请人:The Schepens Eye Research Institute, Inc.
公开号:US20160175380A1
公开(公告)日:2016-06-23
This application discloses pharmaceutical compositions (e.g., oral, parenteral or topical ophthalmic formulations) for treating Fuchs endothelial corneal dystrophy (FECD) with one or more Nrf2 activators and/or mitochondrially targeted antioxidants. The compositions may be topically administered to the eye and are effective in the treatment of FECD. The invention further provides methods of treating FECD by in a subject in need of such treatment by topical application of one or more Nrf2 activators and/or mitochondrially of the invention.